Volatile Week for Coronavirus Stocks: COVID Vaccines are in Focus…Update-5
Update-5 JY 7 After close with NASDAQ down 0.86%, but biotechs hold. Genmark (GNMK) up 10.33% AH to $17.22 on Preliminary q2 Results. Revs of $40.1M, a 118% increase over Q2 2019, Placed 71 new ePlex analyzers for a total installed base of 650. Added to VIR Bio (VIR) up 8.12% to $44.35.Also...
Biotech Breakout -XBI: Portfolio Notes and Composition Update-3
Update-3...June 25-Re-opening Paused in FLA and TX-but stocks rally anyway. NASDAQ leads up 11% YTD. Trading remains volatile e.g. VIR. Bullish trend intact for biotech IBB up 1.11%. Vaccine stocks continue strong: BNTX INO NVAX ; MRNA lagging. Diagnostic leaders today: GNMK up 10.28%, QDEL up...
What’s Next for Coronavirus Stocks? Diagnostics are the Near Term Focus…Update-2
Update-2 6/20...Strong finish for biotech on Friday with XBI up 2.83% to $108.85, up 5.64% for week; and one year high. Coronavirus strong stocks for the week: GNMK HOLX NVAX RGEN TDOC VIR . Quidel (QDEL) rests at $210 handle after rocketing from $170 level on June12. GILD made a big move...
Momentum Trading Shifts to Cyclicals and Industrials but Biotech is in For the Long Run…Update-3 Steroid treatment for COVID!
Update-3 6/16/20 at opening...Futures up on 18% increase in Retail Sales and New Potential coronavirus treatment-Dexamethasone. Low dose steroid treatment is a major breakthrough and can save lives. Coronavirus stocks take a hit: GNMK INO MRNA QDEL, but XBI up 1.79%. Update at the close as...
Coronavirus Stock Scoreboard May 2020…Update-3 Rotation Out of Healthcare and Biotech
June 6... see if the Rotation Trend continues through the Week of June 8 Week Ending June 6 Performance Leaders Energy, Financials, Europe. Laggards: Staples, Healthcare. IBB off 1.95%, XBI off 1%. Stocks to watch: GILD, GSK, VIR June 5...Midday trading-Rotation Rally Continues with DOW up...